Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET
Company Participants
Michael Wood – Investor Relations
Chaim Lebovits – President & Chief Executive Officer
Alla Patlis – Interim Chief Financial Officer
Bob Dagher – Executive Vice President & Chief Medical Officer
Haro Hartounian – Executive Vice President & Chief Operating Officer
Conference Call Participants
Jason McCarthy – Maxim Group
David Bautz – Zacks Small-Cap
Operator
Good morning, everyone, and welcome to BrainStorm Cell Therapeutics Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Michael Wood. Michael, the floor is yours.
Michael Wood
Thank you, operator. Good morning, and thank you for joining us.
Before passing it off to company management for prepared remarks, I’d like to remind listeners on this conference call that it will contain numerous statements, descriptions, forecasts and projections regarding BrainStorm Cell Therapeutics and its potential future business operations and performance statements regarding the market potential of the treatment for neurodegenerative disorders such as ALS, the sufficiency of the company’s existing capital resources for continuing operations in 2025 and beyond, the safety and clinical effectiveness of the NurOwn technology platform, clinical trials of NurOwn and related clinical development programs, and the company’s ability to develop strategic collaborations and partnerships to support their business planning efforts.
Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond BrainStorm’s control, including the risks and uncertainties described from time to time in the company’s SEC filings. The company’s results may differ materially from those projected on today’s call, and we undertake no obligation to publicly update any of these forward-looking statements.
Joining us on the
#Brainstorm #Cell #Therapeutics #BCLI #Earnings #Call #Transcript